Life threatening drug-induced hyperkaliemia - Case report;Jatrogenna hiperkaliemia zagrazȧja̧ca życiu - Opis przypadków klinicznych

Polskie Archiwum Medycyny Wewnetrznej

Volumn 115, Issue 3, 2006, Pages 238-242

  Konopa, Joanna ^a,b   Bullo, Barbara ^a   Rutkowski, Bolesław ^a  

^a Klinika Immunologii   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adverse drug events; Angiotensin converting enzyme inhibitors; Hyperkalemia; Risk factors; Spironolactone

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SPIRONOLACTONE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIALYSIS; FEMALE; HUMAN; HYPERKALEMIA; MALE; MORBIDITY; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; SYMPTOMATOLOGY; CHEMICALLY INDUCED DISORDER; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; HYPERKALEMIA; MALE; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 33746533082     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Juurlink D.N., Mamdani M.M., Lee D.S. i wsp. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004; 351: 543.
2. Palmer B.F.: Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004; 351: 585.
3. Cruz C.S., Cruz A.A., Marcilio de Souza C.A. Hyperkalemia in congestive heart failure patients using ACE inhibitors and spironolactone. Nephrol Dial Traansplant. 2003; 18: 1814.
4. Piepho R.W.: Overview of the angiotensin-converting-enzyme inhibitors. Am J Health Syst Pharm. 2000; 57 suppl. 1: S3.
5. Tomasik T., Windak A., Skalska A. Elektrokardiografia dla lekarza praktyka. 1998, Kraków: Uniwersteckie Wydawnictwo Medyczne "Vasalius".
6. Braunwald E. Atlas chorób wewnȩtrznych. 2003; Wydawnictwo Medyczne Via Medica.
7. Konopa J., Bułło B., Rutkowski B. Późna hiperkaliemia polekowa u pacjentki z niewydolnościa̧ serca. Przegla̧d Lekarski. 2005; 62: 732.
8. Ksia̧żek A., Rutkowski B. Nefrologia. 2004;, Wydawnictwo Czelej.
9. Reardon L.C., Macpherson D.S. Hyperkalemia in outpatients using angiotensin-Converting enzyme inhibitors. How much should we worry? Arch Intern Med. 1998; 158: 26.
10. Acker C.G., Johnson J.P., Palevsky P.M. i wsp. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med. 1998; 158: 917.
11. Kaplan B., Wang Z., Abecassis M.M. i wsp. Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage. Transplantation. 1996; 62: 1174.
12. Kokot F. Gospodarka wodno-elektrolitowa i kwasowo-zasadowa w stanch fizjologii i patologii. 1998, Wydawnictwo Lekarskie PZWL.
13. Nurko S.: At what level of hyperkalemia or creatinine elevation should ACE inhibitor therapy bre stopped or not started? Cleve Clin J Med. 2001; 68: 754, 757, 760.